Targeting chronic inflammation in cerebral aneurysms: focusing on NF-κB as a putative target of medical therapy

Bibliography

• Feigin VL, Findlay M. Advances in subarachnoid hemorrhage. Stroke 2006;37(2):305-8
   PubMedGoogle Scholar
• van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007;369(9558):306-18
   PubMed Web of Science ®Google Scholar
• Olafsson E, Hauser WA, Gudmundsson G. A population-based study of prognosis of ruptured cerebral aneurysm: mortality and recurrence of subarachnoid hemorrhage. Neurology 1997;48(5):1191-5
   PubMedGoogle Scholar
• Findlay JM, Deagle GM. Causes of morbidity and mortality following intracranial aneurysm rupture. Can J Neurol Sci (1998) 25(3):209-15
   PubMedGoogle Scholar
• Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg 2008;108(5):1052-60
   PubMedGoogle Scholar
• White PM, Wardlaw JM. Unruptured intracranial aneurysms. J Neuroradiol 2003;30(5):336-50
   PubMedGoogle Scholar
• Wiebers DO, Whisnant JP, Huston J III, Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362(9378):103-10
   PubMed Web of Science ®Google Scholar
• Ausman JI. “The death of cerebral aneurysm surgery” revisited in 2008. Surg Neurol 2008;70(4):441-2
   PubMedGoogle Scholar
• van der Schaff IC, Brilstra EH, Rinkel GJ, Quality of life, anxiety, and depression in patients with an untreated intracranial aneurysm or arteriovenous malformation. Stroke 2002;33(2):440-3
   PubMedGoogle Scholar
• Chyatte D, Bruno G, Desai S, Inflammation and intracranial aneurysms. Neurosurgery 1999;45(5):1137-46
   PubMedGoogle Scholar
• Frosen J, Piippo A, Paetau A, Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke 2004;35(10):2287-93
   PubMedGoogle Scholar
• Aoki T, Kataoka H, Morimoto M, Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke 2007;38(1):162-9
   PubMedGoogle Scholar
• Inoue K, Mineharu Y, Inoue S, Search on chromosome 17 centromere reveals TNFRSF13B as a susceptibility gene for intracranial aneurysm: a preliminary study. Circulation 2006;113(16):2002-10
   PubMedGoogle Scholar
• Khurana VG, Meissner I, Sohni YR, The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture. J Neurosurg 2005;102(3):526-31
   PubMedGoogle Scholar
• Mineharu Y, Inoue K, Inoue S, Association analyses confirming a susceptibility locus for intracranial aneurysm at chromosome 14q23. J Hum Genet 2008;53(4):325-32
   PubMedGoogle Scholar
• Mineharu Y, Inoue K, Inoue S, Model-based linkage analyses confirm chromosome 19q13.3 as a susceptibility locus for intracranial aneurysm. Stroke 2007;38(4):1174-8
   PubMedGoogle Scholar
• Ozturk AK, Nahed BV, Bydon M, Molecular genetic analysis of two large kindreds with intracranial aneurysms demonstrates linkage to 11q24-25 and 14q23-31. Stroke 2006;37(4):1021-7
   PubMedGoogle Scholar
• Ruigrok YM, Wijmenga C, Rinkel GJ, Genomewide linkage in a large Dutch family with intracranial aneurysms: replication of 2 loci for intracranial aneurysms to chromosome 1p36.11-p36.13 and Xp22.2-p22.32. Stroke 2008;39(4):1096-102
   PubMedGoogle Scholar
• Ruigrok YM, Rinkel GJ. Genetics of intracranial aneurysms. Stroke 2008;39(3):1049-55
   PubMedGoogle Scholar
• van der Voet M, Olson JM, Kuivaniemi H, Intracranial aneurysms in Finnish families: confirmation of linkage and refinement of the interval to chromosome 19q13.3. Am J Hum Genet 2004;74(3):564-71
   PubMedGoogle Scholar
• Yoneyama T, Kasuya H, Onda H, Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm. J Hum Genet 2003;48(6):309-14
   PubMedGoogle Scholar
• Biros E, Golledge J. Meta-analysis of whole-genome linkage scans for intracranial aneurysm. Neurosci Lett 2008;431(1):31-5
   PubMedGoogle Scholar
• Fukuda S, Hashimoto N, Naritomi H, Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation 2000;101(21):2532-8
   PubMedGoogle Scholar
• Moriwaki T, Takagi Y, Sadamasa N, Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke 2006;37(3):900-5
   PubMedGoogle Scholar
• Sadamasa N, Nozaki K, Kita-Matsuo H, Gene expression during the development of experimentally induced cerebral aneurysms. J Vasc Res 2008;45(4):343-9
   PubMedGoogle Scholar
• Sadamasa N, Nozaki K, Hashimoto N. Disruption of gene for inducible nitric oxide synthase reduces progression of cerebral aneurysms. Stroke 2003;34(12):2980-4
   PubMedGoogle Scholar
• Cao Y, Zhao J, Wang S, Monocyte chemoattractant protein-1 mRNA in human intracranial aneurysm walls. Zhonghua Yu Fang Yi Xue Za Zhi 2002;36(7):519-21
   PubMedGoogle Scholar
• Aoki T, Kataoka H, Ishibashi R, Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke 2009;40(3):942-51
   PubMed Web of Science ®Google Scholar
• Jayaraman T, Berenstein V, Li X, Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery 2005;57(3):558-64
   PubMedGoogle Scholar
• Fontanella M, Rainero I, Gallone S, Tumor necrosis factor-alpha gene and cerebral aneurysms. Neurosurgery 2007;60(4):668-72
   PubMedGoogle Scholar
• Krischek B, Kasuya H, Tajima A, Network-based gene expression analysis of intracranial aneurysm tissue reveals role of antigen presenting cells. Neuroscience 2008;154(4):1398-407
   PubMedGoogle Scholar
• Laaksamo E, Tulamo R, Baumann M, Involvement of mitogen-activated protein kinase signaling in growth and rupture of human intracranial aneurysms. Stroke 2008;39(3):886-92
   PubMedGoogle Scholar
• Takagi Y, Ishikawa M, Nozaki K, Increased expression of phosphorylated c-Jun amino-terminal kinase and phosphorylated c-Jun in human cerebral aneurysms: role of the c-Jun amino-terminal kinase/c-Jun pathway in apoptosis of vascular walls. Neurosurgery 2002;51(4):997-1002
   PubMedGoogle Scholar
• Tulamo R, Frosen J, Junnikkala S, Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. Neurosurgery 2006;59(5):1069-76
   PubMed Web of Science ®Google Scholar
• Hashimoto N, Handa H, Hazama F. Experimentally induced cerebral aneurysms in rats. Surg Neurol 1978;10(1):3-8
   PubMedGoogle Scholar
• Hashimoto N, Handa H, Hazama F. Experimentally induced cerebral aneurysms in rats: Part III. Pathology. Surg Neurol 1979;11(4):299-304
   PubMedGoogle Scholar
• Morimoto M, Miyamoto S, Mizoguchi A, Mouse model of cerebral aneurysm: experimental induction by renal hypertension and local hemodynamic changes. Stroke 2002;33(7):1911-15
   PubMedGoogle Scholar
• Nagata I, Handa H, Hashimoto N. Experimentally induced cerebral aneurysms in rats: part IV–cerebral angiography. Surg Neurol 1979;12(5):419-24
   PubMedGoogle Scholar
• Aoki T, Kataoka H, Ishibashi R, Gene expression profile of the intima and media of experimentally induced cerebral aneurysms in rats by laser-microdissection and microarray techniques. Int J Mol Med 2008;22(5):595-603
   PubMedGoogle Scholar
• Aoki T, Kataoka H, Ishibashi R, Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms. Stroke 2008;39(9):2603-10
   PubMedGoogle Scholar
• Aoki T, Kataoka H, Shimamura M, NF-κB is a key mediator of cerebral aneurysm formation. Circulation 2007;116(24):2830-40
   PubMedGoogle Scholar
• Aoki T, Kataoka H, Moriwaki T, Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms. Stroke 2007;38(8):2337-245
   PubMed Web of Science ®Google Scholar
• Aoki T, Nishimura M, Kataoka H, Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox-/- mice. Lab Invest 2009;89(7):730-41
   PubMedGoogle Scholar
• Aoki T, Kataoka H, Ishibashi R, Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-κB. Arterioscler Thromb Vasc Biol 2009;29(7):1080-6
   PubMedGoogle Scholar
• Alnaes MS, Isaksen J, Mardal KA, Computation of hemodynamics in the circle of Willis. Stroke 2007;38(9):2500-5
   PubMedGoogle Scholar
• Castro MA, Putman CM, Sheridan MJ, Hemodynamic patterns of anterior communicating artery aneurysms: a possible association with rupture. AJNR Am J Neuroradiol 2009;30(2):297-302
   PubMedGoogle Scholar
• Jou LD, Lee DH, Morsi H, Wall shear stress on ruptured and unruptured intracranial aneurysms at the internal carotid artery. AJNR Am J Neuroradiol 2008;29(9):1761-7
   PubMedGoogle Scholar
• Mantha A, Karmonik C, Benndorf G, Hemodynamics in a cerebral artery before and after the formation of an aneurysm. AJNR Am J Neuroradiol 2006;27(5):1113-8
   PubMedGoogle Scholar
• Jamous MA, Nagahiro S, Kitazato KT, Endothelial injury and inflammatory response induced by hemodynamic changes preceding intracranial aneurysm formation: experimental study in rats. J Neurosurg 2007;107(2):405-11
   PubMed Web of Science ®Google Scholar
• Pentimalli L, Modesti A, Vignati A, Role of apoptosis in intracranial aneurysm rupture. J Neurosurg 2004;101(6):1018-25
   PubMedGoogle Scholar
• Guo F, Li Z, Song L, Increased apoptosis and cysteinyl aspartate specific protease-3 gene expression in human intracranial aneurysm. J Clin Neurosci 2007;14(6):550-5
   PubMedGoogle Scholar
• Kondo S, Hashimoto N, Kikuchi H, Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke 1998;29(1):181-8
   PubMedGoogle Scholar
• Trackman PC. Diverse biological functions of extracellular collagen processing enzymes. J Cell Biochem 2005;96(5):927-37
   PubMedGoogle Scholar
• Gaetani P, Tartara F, Grazioli V, Collagen cross-linkage, elastolytic and collagenolytic activities in cerebral aneurysms: a preliminary investigation. Life Sci 1998;63(4):285-92
   PubMedGoogle Scholar
• Gaetani P, Grazioli V, Tancioni F, Abnormalities of collagen cross-linkage in posterior communicating artery aneurysms: a preliminary study. Neurol Res 1996;18(6):541-5
   PubMedGoogle Scholar
• Ruigrok YM, Tan S, Medic J, Genes involved in the transforming growth factor beta signalling pathway and the risk of intracranial aneurysms. J Neurol Neurosurg Psychiatry 2008;79(6):722-4
   PubMedGoogle Scholar
• Bruno G, Todor R, Lewis I, Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg 1998;89(3):431-40
   PubMedGoogle Scholar
• Jin D, Sheng J, Yang X, Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm. Surg Neurol 2007;68(Suppl 2):S11-16
   Google Scholar
• Kim SC, Singh M, Huang J, Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery 1997;41(3):642-66
   PubMedGoogle Scholar
• Chyatte D, Lewis I. Gelatinase activity and the occurrence of cerebral aneurysms. Stroke 1997;28(4):799-804
   PubMedGoogle Scholar
• Aoki T, Kataoka H, Ishibashi R, Nifedipine inhibits the progression of an experimentally induced cerebral aneurysm in rats with associated down-regulation of NF-kappa B transcriptional activity. Curr Neurovasc Res 2008;5(1):37-45
   PubMedGoogle Scholar
• Aoki T, Kataoka H, Ishibashi R, Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor κB pathway. Neurosurgery 2009;64(2):357-65
   PubMedGoogle Scholar
• Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta Protein Struct Mol Enzymol 2000;1477(1-2):267-83
   PubMedGoogle Scholar
• Unruptured intracranial aneurysms–risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med 1998;339(24):1725-33
   PubMed Web of Science ®Google Scholar
• Todd PA, Goa KL. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs 1990;40(4):583-607
   PubMedGoogle Scholar
• Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89-118
   PubMed Web of Science ®Google Scholar
• Aoki T, Kataoka H, Ishibashi R, Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke 2008;39(4):1276-85
   PubMedGoogle Scholar
• Kalyanasundaram A, Elmore JR, Manazer JR, Simvastatin suppresses experimental aortic aneurysm expansion. J Vasc Surg 2006;43(1):117-24
   PubMedGoogle Scholar
• Schouten O, van Laanen JH, Boersma E, Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 2006;32(1):21-6
   PubMedGoogle Scholar
• Morishita R, Sugimoto T, Aoki M, In vivo transfection of cis element “decoy” against nuclear factor-κB binding site prevents myocardial infarction. Nat Med 1997;3(8):894-9
   PubMedGoogle Scholar
• Clarke M. Systematic review of reviews of risk factors for intracranial aneurysms. Neuroradiology 2008;50(8):653-64
   PubMedGoogle Scholar
• Feigin VL, Rinkel GJ, Lawes CM, Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005;36(12):2773-80
   PubMedGoogle Scholar
• Gu YX, Chen XC, Song DL, Risk factors for intracranial aneurysm in a Chinese ethnic population. Chin Med J (Engl) 2006;119(16):1359-64
   PubMedGoogle Scholar
• Thurmann PA. Valsartan: a novel angiotensin type 1 receptor antagonist. Expert Opin Pharmacother 2000;1(2):337-50
   PubMedGoogle Scholar
• Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000;105(11):1605-12
   PubMedGoogle Scholar
• Daugherty A, Rateri DL, Cassis LA. Role of the renin–angiotensin system in the development of abdominal aortic aneurysms in animals and humans. Ann NY Acad Sci 2006;1085:82-91
   PubMedGoogle Scholar
• Daugherty A, Manning MW, Cassis LA. Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001;134(4):865-70
   PubMedGoogle Scholar
• Iwai M, Chen R, Li Z, Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 2005;112(11):1636-43
   PubMedGoogle Scholar
• Liao S, Miralles M, Kelley BJ, Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg 2001;33(5):1057-64
   PubMedGoogle Scholar
• Ohkuma H, Suzuki S, Fujita S, Role of a decreased expression of the local renin-angiotensin system in the etiology of cerebral aneurysms. Circulation 2003;108(7):785-7
   PubMedGoogle Scholar
• Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot (Lond) 2003;91:179-94
   PubMed Web of Science ®Google Scholar
• Winrow VR, Winyard PG, Morris CJ, Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull 1993;49(3):506-22
   PubMedGoogle Scholar
• Kaufmann TJ, Marx WF, Kallmes DF. A failure of matrix metalloproteinase inhibition in the prevention of rat intracranial aneurysm formation. Neuroradiology 2006;48(3):190-5
   PubMedGoogle Scholar